Group 1 - The company, Lepu Medical, plans to invest 20 million yuan in establishing a venture capital fund focused on molecular diagnostics and targeted therapies in the biopharmaceutical sector [1] - The total committed capital for the fund is 35 million yuan, with Lepu Medical contributing 20 million yuan from its own funds [1] - The fund will primarily invest in unlisted companies across the entire industry chain related to molecular diagnostics, targeted therapies, and associated professional services [1]